DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / NTI Managers, LLC
NTI Managers, LLC
Leverage the expertise of hundreds of physician leaders from around the world who identify, codevelop and guide the evolution of medical innovation.
venture manager, reported GAV $42.5M across 7 vehicles
Importance
23
moderate
Active deployment
15
moderate
Emerging
0
low
Completeness
63
high
Freshness
100
high
Research priority
8
low
Identity and regulatory footprint
- Headquarters
- Mountain View, CAadviserinfo.sec.gov
- Office address
- 2500 OLD MIDDLEFIELD WAY, STE. E, Mountain View, CA, 94043adviserinfo.sec.gov
- Business phone
- 669-250-2240adviserinfo.sec.gov
- Website
- https://themdadvantage.com/
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 7, 2026
- Private funds reported
- 9 (9 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $56.2Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Reist, LLC (Member), B
- business phone
- 669-250-2240adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
4 observed deals
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 4
Funds and vehicles
7 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Neurotechnology Investors II, LLC | Fund | 2020 form d first sale | Mature | $14.0M Jul 26, 2024 | 90 | $189,600 of $189,600 | Mar 18, 2020 |
| Neurotechnology Investors, LLC | Fund | 2018 form d first sale | Harvest | $10.0M Jul 26, 2024 | 73 | $244,692 of $1.0M | Oct 18, 2018 |
| Neurotechnology Partners Fund, LLC | Fund | unknown | Unknown | $6.2M Jul 26, 2024 | 8 | unknown | unknown |
| Neurotechnology Investors III, LLC | Fund | unknown | Unknown | $5.8M Jul 26, 2024 | 96 | unknown | unknown |
| Neurotechnology Investors V, LLC | Fund | unknown | Unknown | $4.2M Jul 26, 2024 | 54 | unknown | unknown |
| Neurotechnology Investors IV, LLC | Fund | unknown | Unknown | $2.3M Jul 26, 2024 | 61 | unknown | unknown |
| NTI Stroke Diagnostics, LLC | SPV or co-invest vehicle · ADV: Other Private Fund | unknown | Unknown | $296 Jul 26, 2024 | 48 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
5 current, 0 departed
Adnan Siddiqui
PartnerMember · since May 1, 2016
Aquilla Turk
PartnerMember · since May 1, 2016
Dieck Martin
PartnerMember · since May 1, 2016
J Mocco
PartnerMember · since May 1, 2016
Josephine Siddiqui
PartnerMember · since Oct 1, 2018
Investments on record
4 edges, 4 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| MD-driven partnership | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stroke Diagnostics, LLC | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| Cookiedatabase | portfolio listing | unknown | unknown | unknown | unknown | Sep 12, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| Site by BKW | portfolio listing | unknown | unknown | unknown | unknown | Sep 12, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
10 relationships from shared deals, counted for the whole firm
Alpha Partners Management, LLC 1 shared · one timeRockwood Equity Partners LLC 1 shared · one timeYork Investments Holdings, LLC 1 shared · one timeCota Capital Management, LLC 1 shared · one timeOmega Venture Partners 1 shared · one timeArboretum Ventures 1 shared · one timeOrbiMed 1 shared · one timeSUN Mountain Capital Advisors, LLC 1 shared · one timePlexo Capital Management, LLC 1 shared · one timeRice Park Capital 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
- Sep 16, 2026Cookiedatabase no longer listed on NTI Managers, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceCookiedatabaseVenture organization websites (about, team, portfolio, thesis, news pages)
- Jul 26, 2024Neurotechnology Investors II, LLC first reported on Form ADV by NTI Managers, LLC (Venture Capital Fund), GAV $13,975,309Fund first reported on Form ADVFundsFactNeurotechnology Investors II, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 26, 2024Neurotechnology Investors IV, LLC first reported on Form ADV by NTI Managers, LLC (Venture Capital Fund), GAV $2,288,900Fund first reported on Form ADVFundsFactNeurotechnology Investors IV, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 26, 2024Neurotechnology Investors III, LLC first reported on Form ADV by NTI Managers, LLC (Venture Capital Fund), GAV $5,814,900Fund first reported on Form ADVFundsFactNeurotechnology Investors III, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 26, 2024NTI Managers, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 26, 2024NTI Stroke Diagnostics, LLC first reported on Form ADV by NTI Managers, LLC (Other Private Fund), GAV $296Fund first reported on Form ADVFundsFactNTI Stroke Diagnostics, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 26, 2024Neurotechnology Partners Fund, LLC first reported on Form ADV by NTI Managers, LLC (Venture Capital Fund), GAV $6,208,000Fund first reported on Form ADVFundsFactNeurotechnology Partners Fund, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 26, 2024Neurotechnology Investors, LLC first reported on Form ADV by NTI Managers, LLC (Venture Capital Fund), GAV $10,039,934Fund first reported on Form ADVFundsFactNeurotechnology Investors, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 26, 2024Neurotechnology Investors V, LLC first reported on Form ADV by NTI Managers, LLC (Venture Capital Fund), GAV $4,189,346Fund first reported on Form ADVFundsFactNeurotechnology Investors V, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Micro VC (confirmed, 95%, cls-1)venture manager, reported GAV $42.5M across 7 vehicles
Evidence
36 observations from 3 sources